Retraction Note: OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation(Cell Death Dis, (2014), 10.1038/cddis.2013.563);OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation

Cell Death and Disease

Volumn 5, Issue 1, 2014, Pages e1024-

  Ng, W L ^a   Chen, G ^a   Wang, M ^b   Wang, H ^a   Story, M ^c   Shay, J W ^d   Zhang, X ^a   Wang, J ^a   Amin, A R M R ^a   Hu, B ^a,e   Cucinotta, F A ^f   Wang, Y ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^f UNIVERSITY OF NEVADA   (United States)

Author keywords

Cell Transformation; miR 34a; OCT4; p53; p63

Indexed keywords

MICRORNA; MIRN34 MICRORNA, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; PROTEIN P53; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN BINDING;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84906911102     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/s41419-022-04665-4     Document Type: Erratum

References (55)

1. Dimri G, Band H, Band V. Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res 2005; 7: 171–179. DOI: 10.1186/bcr1275
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676. DOI: 10.1016/j.cell.2006.07.024
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872.
4. Anokye-Danso F, Trivedi Chinmay M, Juhr D, Gupta M, Cui Z, Tian Y et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376–388. DOI: 10.1016/j.stem.2011.03.001
5. Choi YJ, Lin C-P, Ho JJ, He X, Okada N, Bu P et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13: 1353–1360. DOI: 10.1038/ncb2366
6. Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, Zwaka TP et al. p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 2012; 10: e1001268. DOI: 10.1371/journal.pbio.1001268
7. Lin T, Chao C, Saito Si, Mazur SJ, Murphy ME, Appella E et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165–171. DOI: 10.1038/ncb1211
8. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17: 211–215. DOI: 10.1038/nm.2284
9. McKeon F. p63 and the epithelial stem cell: more than status quo? Genes Dev 2004; 18: 465–469. DOI: 10.1101/gad.1190504
10. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98: 3156–3161. DOI: 10.1073/pnas.061032098
11. Senoo M, Pinto F, Crum CP, McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523–536. DOI: 10.1016/j.cell.2007.02.045
12. Wang X, Ouyang H, Yamamoto Y, Kumar Pooja A, Wei Tay S, Dagher R et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145: 1023–1035. DOI: 10.1016/j.cell.2011.05.026
13. Belyi VA, Levine AJ. One billion years of p53/p63/p73 evolution. Proc Natl Acad Sci USA 2009; 106: 17609–17610. DOI: 10.1073/pnas.0910634106
14. Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW et al. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 2009; 11: 1451–1457. DOI: 10.1038/ncb1988
15. Livera G, Petre-Lazar B, Guerquin MJ, Trautmann E, Coffigny H, Habert R. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 2008; 135: 3–12. DOI: 10.1530/REP-07-0054
16. Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 2010; 107: 246–251. DOI: 10.1073/pnas.0908428107
17. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin Y-L et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010; 467: 986–990. DOI: 10.1038/nature09459
18. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 2012; 109: 15312–15317. DOI: 10.1073/pnas.1110977109
19. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415: 45–53. DOI: 10.1038/415045a
20. Crum CP, McKeon FD. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5: 349–371. DOI: 10.1146/annurev-pathol-121808-102117
21. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233–1238. DOI: 10.1126/science.1978757
22. Celli J, Duijf P, Hamel BCJ, Bamshad M, Kramer B, Smits APT et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99: 143–153. DOI: 10.1016/S0092-8674(00)81646-3
23. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714–718. DOI: 10.1038/19539
24. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM et al. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735–742. DOI: 10.1158/1541-7786.MCR-07-2102
25. Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Inv Ophthal Visual Sci 2009; 50: 4542–4551. DOI: 10.1167/iovs.09-3520
26. Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev 2013; 23: 3–1. DOI: 10.1016/j.gde.2013.01.004
27. Kasinski AL, Slack FJ. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 2012; 72: 5576–5587. DOI: 10.1158/0008-5472.CAN-12-2001
28. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472–15477. DOI: 10.1073/pnas.0707351104
29. Yin D, Ogawa S, Kawamata N, Leiter A, Ham M, Li D et al. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene 2013; 32: 1155–1163. DOI: 10.1038/onc.2012.132
30. Antonini D, Russo MT, De Rosa L, Gorrese M, Del Vecchio L, Missero C. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol 2010; 130: 1249–1257. DOI: 10.1038/jid.2009.438
31. Chang T-C, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee Kwang H et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745–752. DOI: 10.1016/j.molcel.2007.05.010
32. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130–1134. DOI: 10.1038/nature05939
33. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731–743. DOI: 10.1016/j.molcel.2007.05.017
34. Blanpain C, Fuchs E. p63: revving up epithelial stem-cell potential. Nat Cell Biol 2007; 9: 731–733. DOI: 10.1038/ncb0707-731
35. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18: 126–131. DOI: 10.1101/gad.1165104
36. Su X, Paris M, Gi YJ, Tsai KY, Cho MS, Lin Y-L et al. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 2009; 5: 64–75. DOI: 10.1016/j.stem.2009.04.003
37. Hall E, Giaccia A. Radiobiology for the Radiologist. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006.
38. Durante M, Cucinotta FA. Heavy ion carcinogenesis and human space exploration. Nat Rev Cancer 2008; 8: 465–472. DOI: 10.1038/nrc2391
39. Jung M, Peterson H, Chavez L, Kahlem P, Lehrach H, Vilo J et al. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS One 2010; 5: e10709. DOI: 10.1371/journal.pone.0010709
40. Scholer HR, Balling R, Hatzopoulos AK, Suzuki N, Gruss P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. Embo J 1989; 8: 2551–2557. DOI: 10.1002/j.1460-2075.1989.tb08393.x
41. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009; 137: 647–658. DOI: 10.1016/j.cell.2009.02.038
42. Liu L, Roberts RM. Silencing of the gene for the β subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4. J Biol Chem 1996; 271: 16683–16689. DOI: 10.1074/jbc.271.28.16683
43. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004; 64: 9027–9034. DOI: 10.1158/0008-5472.CAN-04-3703
44. Wang X, Dai J. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 2010; 28: 885–893. DOI: 10.1002/stem.542
45. Kastler S, Honold L, Luedeke M, Kuefer R, Moller P, Hoegel J et al. POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate 2010; 70: 666–674.
46. Panagopoulos I, Moller E, Collin A, Mertens F. The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep 2008; 20: 1029–1033.
47. Beltran AS, Rivenbark AG, Richardson BT, Yuan X, Quian H, Hunt JP et al. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res 2011; 13: R94. DOI: 10.1186/bcr3019
48. Gallant-Behm CL, Ramsey MR, Bensard CL, Nojek I, Tran J, Liu M et al. ΔNp63α represses anti-proliferative genes via H2A.Z deposition. Genes Dev 2012; 26: 2325–2336. DOI: 10.1101/gad.198069.112
49. Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee C-CR et al. ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 2003; 63: 2351–2357.
50. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4: 793–805. DOI: 10.1038/nrc1455
51. Keyes WM, Vogel H, Koster MI, Guo X, Qi Y, Petherbridge KM et al. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc Natl Acad Sci USA 2006; 103: 8435–8440. DOI: 10.1073/pnas.0602477103
52. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003; 63: 7113–7121.
53. Essers J, Hendriks RW, Swagemakers SMA, Troelstra C, de Wit J, Bootsma D et al. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 1997; 89: 195–204. DOI: 10.1016/S0092-8674(00)80199-3
54. Zhang X, Ng W-L, Wang P, Tian L, Werner E, Wang H et al. MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFα. Cancer Res 2012; 72: 4707–4713. DOI: 10.1158/0008-5472.CAN-12-0639
55. Szulc J, Wiznerowicz M, Sauvain M-O, Trono D, Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat Meth 2006; 3: 109–116. DOI: 10.1038/nmeth846